The United Kingdom has historically established itself as a “scientific superpower.” The birthplace of discoveries that have transformed global medicine, the country remains at the forefront of biotechnology and academic research. However, a critical question echoes in the corridors of healthcare institutions: why are British patients often the last to benefit from innovations created in their own backyard?
To discuss this scenario, the Royal Society of Medicine in London will host the prestigious Stevens Lecture 2026 on May 18th, which this year will be led by Dame Kate Bingham.
The Gap Between the Lab and the Bedside:
Dame Kate Bingham, managing partner at SV Health Investors and a key figure in the UK’s biomedical strategy, will provide an in-depth analysis of what she defines as the “distribution gap.” The phenomenon is intriguing and worrying: innovative medicines and therapies developed on British soil reach the health systems of other countries with a speed that even the NHS (National Health Service) seems unable to replicate.
According to the event preview, the lecture will address three fundamental pillars:
Structural Barriers: The bureaucratic and logistical obstacles that prevent the rapid adoption of new technologies in the public system.
Investment vs. Adoption: How a country manages to attract capital for discovery, but fails to sustain the cycle to final clinical application.
The Human Impact: The direct consequences for patients who face a lack of access to life-saving treatments, despite being geographically close to where they were raised.
An Expert at the Intersection of Worlds:
Bingham’s selection for the Stevens Lecture is no accident. With a career built at the intersection of scientific innovation, venture capital, and public policy, she possesses a privileged view of the entire healthcare production chain.
Their expertise will allow them to dissect the manufacturing and distribution process, as well as assess how emerging technologies—from genomics to artificial intelligence—are transforming medicine, while also exposing the weaknesses of a healthcare system struggling to modernize.
“Why does a nation so brilliant at discovery so often fail to implement it?” This is the central question that will guide the debate, serving as a call for healthcare professionals, scientists, and policymakers to reflect on the future of medical sustainability in the United Kingdom.
Event Details:
This meeting is aimed at both specialists and the general public interested in the impact of science on society. It is a rare opportunity to hear one of the most influential voices in contemporary biomedicine on the sector’s most pressing challenge.
Event: Stevens Lecture 2026, by Dame Kate Bingham
Date: Monday, May 18, 2026
Time: 6:00 PM – 8:15 PM
Location: Royal Society of Medicine, London.
